Rovaldi Christopher

Track

Insider profile

Rovaldi Christopher's trades of Keros Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
450.26
Quantity 14,198
Value US$934,487
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-12 2025-09-12
PrS Proposed sale
14,198
450.26
US$934,487 		14,198 450.26 US$934,487
2022-04-08 2022-04-06
PlS Planned sale
62,869 -24.6%
322.50
US$1,505,364 		62,869 -24.6% 322.50 US$1,505,364
2022-04-05 2022-04-01
PlS Planned sale
19,981 -9.6%
495.38
US$465,888 		19,981 -9.6% 495.38 US$465,888
2022-04-05 2022-04-01
PlS Planned sale
366 -77.7%
57.97
US$21,217 		366 -77.7% 57.97 US$21,217
2022-04-05 2022-04-01
PlS Planned sale
287 -37.9%
56.89
US$16,327 		287 -37.9% 56.89 US$16,327
2022-04-05 2022-04-01
PlS Planned sale
104 -12.1%
56.20
US$5,845 		104 -12.1% 56.20 US$5,845
2022-04-05 2022-04-01
PlS Planned sale
2 -0.2%
54.34
US$109 		2 -0.2% 54.34 US$109